Atherosclerotic plaque epigenetic age acceleration is characterized by mesenchymal reprogramming and poor prognosis https://www.medrxiv.org/content/10.1101/2023.02.16.23286067
Atherosclerotic plaque epigenetic age acceleration is characterized by mesenchymal reprogramming and poor prognosis https://www.medrxiv.org/content/10.1101/2023.02.16.23286067